ENZO BIOCHEM INC SEC Filings

Filed On	Filing
14 Nov 2025	SCHEDULE 13G/A
29 Aug 2025	EFFECT
29 Aug 2025	EFFECT
22 Aug 2025	SCHEDULE 13D/A
20 Aug 2025	FORM 15-12G
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO TO FORM S-8
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
20 Aug 2025	POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3
20 Aug 2025	Form 4: Radoff Bradley Louis, Director Returned 4,963,779 shares to the issuer
20 Aug 2025	Form 4: Pully Steven J, Director Returned 239,992 shares to the issuer
20 Aug 2025	Form 4: Eckert Patricia, Chief Financial Officer Returned 28,328 shares to the issuer · Disposed of 275,000 Stock Option (to acquire shares of Common Stock) (Disposition to Issuer)

Comments